ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rubella Recombinant Antigen Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-22Q17873
Home | Market Reports | Science| Biological Sciences
Global Rubella Recombinant Antigen Market Research Report 2024
BUY CHAPTERS

Global Rubella Recombinant Antigen Market Research Report 2024

Code: QYRE-Auto-22Q17873
Report
August 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Creative BioMart
RayBiotech
ProSpec
Abcam
Bio Rad Laboratories
Fapon Biotech
QED Bioscience
Cusabio
Meridian Bioscience
Native Antigen Company
SERION Immunologics
ViroGen Corporation

Rubella Recombinant Antigen Market

Rubella Recombinant Antigen is a protein produced by genetic engineering technology that mimics the natural antigen of the rubella virus. Rubella virus is the virus that causes rubella, a common infectious disease that is particularly dangerous in pregnant women because infection may lead to congenital rubella syndrome in the fetus. Recombinant antigens are used in in vitro diagnostic reagents to detect immune responses caused by rubella infection (such as the presence of antibodies), and are used in vaccine development and basic research.
The global Rubella Recombinant Antigen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Rubella Recombinant Antigen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rubella Recombinant Antigen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rubella Recombinant Antigen in In Vitro Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rubella Recombinant Antigen include Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rubella Recombinant Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Recombinant Antigen.
The Rubella Recombinant Antigen market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rubella Recombinant Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Recombinant Antigen companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rubella Recombinant Antigen Market Report

Report Metric Details
Report Name Rubella Recombinant Antigen Market
Segment by Type
  • Rubella Protein Purity >90%
  • Rubella Protein Purity >95%
  • Rubella Protein Purity >98%
  • Others
Segment by Application
  • In Vitro Diagnostics
  • Vaccine Development
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, SERION Immunologics, ViroGen Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rubella Recombinant Antigen company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rubella Recombinant Antigen Market report?

Ans: The main players in the Rubella Recombinant Antigen Market are Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, SERION Immunologics, ViroGen Corporation

What are the Application segmentation covered in the Rubella Recombinant Antigen Market report?

Ans: The Applications covered in the Rubella Recombinant Antigen Market report are In Vitro Diagnostics, Vaccine Development, Others

What are the Type segmentation covered in the Rubella Recombinant Antigen Market report?

Ans: The Types covered in the Rubella Recombinant Antigen Market report are Rubella Protein Purity >90%, Rubella Protein Purity >95%, Rubella Protein Purity >98%, Others

Recommended Reports

Recombinant Antigens

Recombinant Vaccines

Recombinant Proteins & Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Recombinant Antigen Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rubella Protein Purity >90%
1.2.3 Rubella Protein Purity >95%
1.2.4 Rubella Protein Purity >98%
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rubella Recombinant Antigen Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In Vitro Diagnostics
1.3.3 Vaccine Development
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Recombinant Antigen Market Perspective (2019-2030)
2.2 Global Rubella Recombinant Antigen Growth Trends by Region
2.2.1 Global Rubella Recombinant Antigen Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rubella Recombinant Antigen Historic Market Size by Region (2019-2024)
2.2.3 Rubella Recombinant Antigen Forecasted Market Size by Region (2025-2030)
2.3 Rubella Recombinant Antigen Market Dynamics
2.3.1 Rubella Recombinant Antigen Industry Trends
2.3.2 Rubella Recombinant Antigen Market Drivers
2.3.3 Rubella Recombinant Antigen Market Challenges
2.3.4 Rubella Recombinant Antigen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Recombinant Antigen Players by Revenue
3.1.1 Global Top Rubella Recombinant Antigen Players by Revenue (2019-2024)
3.1.2 Global Rubella Recombinant Antigen Revenue Market Share by Players (2019-2024)
3.2 Global Rubella Recombinant Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rubella Recombinant Antigen Revenue
3.4 Global Rubella Recombinant Antigen Market Concentration Ratio
3.4.1 Global Rubella Recombinant Antigen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Recombinant Antigen Revenue in 2023
3.5 Global Key Players of Rubella Recombinant Antigen Head office and Area Served
3.6 Global Key Players of Rubella Recombinant Antigen, Product and Application
3.7 Global Key Players of Rubella Recombinant Antigen, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Recombinant Antigen Breakdown Data by Type
4.1 Global Rubella Recombinant Antigen Historic Market Size by Type (2019-2024)
4.2 Global Rubella Recombinant Antigen Forecasted Market Size by Type (2025-2030)
5 Rubella Recombinant Antigen Breakdown Data by Application
5.1 Global Rubella Recombinant Antigen Historic Market Size by Application (2019-2024)
5.2 Global Rubella Recombinant Antigen Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rubella Recombinant Antigen Market Size (2019-2030)
6.2 North America Rubella Recombinant Antigen Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rubella Recombinant Antigen Market Size by Country (2019-2024)
6.4 North America Rubella Recombinant Antigen Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Recombinant Antigen Market Size (2019-2030)
7.2 Europe Rubella Recombinant Antigen Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rubella Recombinant Antigen Market Size by Country (2019-2024)
7.4 Europe Rubella Recombinant Antigen Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Recombinant Antigen Market Size (2019-2030)
8.2 Asia-Pacific Rubella Recombinant Antigen Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2019-2024)
8.4 Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Recombinant Antigen Market Size (2019-2030)
9.2 Latin America Rubella Recombinant Antigen Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rubella Recombinant Antigen Market Size by Country (2019-2024)
9.4 Latin America Rubella Recombinant Antigen Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Recombinant Antigen Market Size (2019-2030)
10.2 Middle East & Africa Rubella Recombinant Antigen Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2019-2024)
10.4 Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biomart
11.1.1 Creative Biomart Company Details
11.1.2 Creative Biomart Business Overview
11.1.3 Creative Biomart Rubella Recombinant Antigen Introduction
11.1.4 Creative Biomart Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.1.5 Creative Biomart Recent Development
11.2 RayBiotech
11.2.1 RayBiotech Company Details
11.2.2 RayBiotech Business Overview
11.2.3 RayBiotech Rubella Recombinant Antigen Introduction
11.2.4 RayBiotech Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.2.5 RayBiotech Recent Development
11.3 ProSpec
11.3.1 ProSpec Company Details
11.3.2 ProSpec Business Overview
11.3.3 ProSpec Rubella Recombinant Antigen Introduction
11.3.4 ProSpec Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.3.5 ProSpec Recent Development
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Rubella Recombinant Antigen Introduction
11.4.4 Abcam Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.4.5 Abcam Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Rubella Recombinant Antigen Introduction
11.5.4 Bio-Rad Laboratories Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Fapon Biotech
11.6.1 Fapon Biotech Company Details
11.6.2 Fapon Biotech Business Overview
11.6.3 Fapon Biotech Rubella Recombinant Antigen Introduction
11.6.4 Fapon Biotech Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.6.5 Fapon Biotech Recent Development
11.7 QED Bioscience
11.7.1 QED Bioscience Company Details
11.7.2 QED Bioscience Business Overview
11.7.3 QED Bioscience Rubella Recombinant Antigen Introduction
11.7.4 QED Bioscience Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.7.5 QED Bioscience Recent Development
11.8 Cusabio
11.8.1 Cusabio Company Details
11.8.2 Cusabio Business Overview
11.8.3 Cusabio Rubella Recombinant Antigen Introduction
11.8.4 Cusabio Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.8.5 Cusabio Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Rubella Recombinant Antigen Introduction
11.9.4 Meridian Bioscience Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.9.5 Meridian Bioscience Recent Development
11.10 Native Antigen Company
11.10.1 Native Antigen Company Company Details
11.10.2 Native Antigen Company Business Overview
11.10.3 Native Antigen Company Rubella Recombinant Antigen Introduction
11.10.4 Native Antigen Company Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.10.5 Native Antigen Company Recent Development
11.11 SERION Immunologics
11.11.1 SERION Immunologics Company Details
11.11.2 SERION Immunologics Business Overview
11.11.3 SERION Immunologics Rubella Recombinant Antigen Introduction
11.11.4 SERION Immunologics Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.11.5 SERION Immunologics Recent Development
11.12 ViroGen Corporation
11.12.1 ViroGen Corporation Company Details
11.12.2 ViroGen Corporation Business Overview
11.12.3 ViroGen Corporation Rubella Recombinant Antigen Introduction
11.12.4 ViroGen Corporation Revenue in Rubella Recombinant Antigen Business (2019-2024)
11.12.5 ViroGen Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Creative BioMart
RayBiotech
ProSpec
Abcam
Bio Rad Laboratories
Fapon Biotech
QED Bioscience
Cusabio
Meridian Bioscience
Native Antigen Company
SERION Immunologics
ViroGen Corporation
List of Tables
 Table 1. Global Rubella Recombinant Antigen Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Rubella Protein Purity >90%
 Table 3. Key Players of Rubella Protein Purity >95%
 Table 4. Key Players of Rubella Protein Purity >98%
 Table 5. Key Players of Others
 Table 6. Global Rubella Recombinant Antigen Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Rubella Recombinant Antigen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Rubella Recombinant Antigen Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Rubella Recombinant Antigen Market Share by Region (2019-2024)
 Table 10. Global Rubella Recombinant Antigen Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Rubella Recombinant Antigen Market Share by Region (2025-2030)
 Table 12. Rubella Recombinant Antigen Market Trends
 Table 13. Rubella Recombinant Antigen Market Drivers
 Table 14. Rubella Recombinant Antigen Market Challenges
 Table 15. Rubella Recombinant Antigen Market Restraints
 Table 16. Global Rubella Recombinant Antigen Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Rubella Recombinant Antigen Market Share by Players (2019-2024)
 Table 18. Global Top Rubella Recombinant Antigen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Recombinant Antigen as of 2023)
 Table 19. Ranking of Global Top Rubella Recombinant Antigen Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Rubella Recombinant Antigen Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Rubella Recombinant Antigen, Headquarters and Area Served
 Table 22. Global Key Players of Rubella Recombinant Antigen, Product and Application
 Table 23. Global Key Players of Rubella Recombinant Antigen, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Rubella Recombinant Antigen Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Rubella Recombinant Antigen Revenue Market Share by Type (2019-2024)
 Table 27. Global Rubella Recombinant Antigen Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Rubella Recombinant Antigen Revenue Market Share by Type (2025-2030)
 Table 29. Global Rubella Recombinant Antigen Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Rubella Recombinant Antigen Revenue Market Share by Application (2019-2024)
 Table 31. Global Rubella Recombinant Antigen Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Rubella Recombinant Antigen Revenue Market Share by Application (2025-2030)
 Table 33. North America Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Rubella Recombinant Antigen Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Rubella Recombinant Antigen Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Rubella Recombinant Antigen Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Rubella Recombinant Antigen Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Rubella Recombinant Antigen Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Rubella Recombinant Antigen Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Rubella Recombinant Antigen Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Rubella Recombinant Antigen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Rubella Recombinant Antigen Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Creative Biomart Company Details
 Table 49. Creative Biomart Business Overview
 Table 50. Creative Biomart Rubella Recombinant Antigen Product
 Table 51. Creative Biomart Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 52. Creative Biomart Recent Development
 Table 53. RayBiotech Company Details
 Table 54. RayBiotech Business Overview
 Table 55. RayBiotech Rubella Recombinant Antigen Product
 Table 56. RayBiotech Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 57. RayBiotech Recent Development
 Table 58. ProSpec Company Details
 Table 59. ProSpec Business Overview
 Table 60. ProSpec Rubella Recombinant Antigen Product
 Table 61. ProSpec Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 62. ProSpec Recent Development
 Table 63. Abcam Company Details
 Table 64. Abcam Business Overview
 Table 65. Abcam Rubella Recombinant Antigen Product
 Table 66. Abcam Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 67. Abcam Recent Development
 Table 68. Bio-Rad Laboratories Company Details
 Table 69. Bio-Rad Laboratories Business Overview
 Table 70. Bio-Rad Laboratories Rubella Recombinant Antigen Product
 Table 71. Bio-Rad Laboratories Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 72. Bio-Rad Laboratories Recent Development
 Table 73. Fapon Biotech Company Details
 Table 74. Fapon Biotech Business Overview
 Table 75. Fapon Biotech Rubella Recombinant Antigen Product
 Table 76. Fapon Biotech Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 77. Fapon Biotech Recent Development
 Table 78. QED Bioscience Company Details
 Table 79. QED Bioscience Business Overview
 Table 80. QED Bioscience Rubella Recombinant Antigen Product
 Table 81. QED Bioscience Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 82. QED Bioscience Recent Development
 Table 83. Cusabio Company Details
 Table 84. Cusabio Business Overview
 Table 85. Cusabio Rubella Recombinant Antigen Product
 Table 86. Cusabio Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 87. Cusabio Recent Development
 Table 88. Meridian Bioscience Company Details
 Table 89. Meridian Bioscience Business Overview
 Table 90. Meridian Bioscience Rubella Recombinant Antigen Product
 Table 91. Meridian Bioscience Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 92. Meridian Bioscience Recent Development
 Table 93. Native Antigen Company Company Details
 Table 94. Native Antigen Company Business Overview
 Table 95. Native Antigen Company Rubella Recombinant Antigen Product
 Table 96. Native Antigen Company Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 97. Native Antigen Company Recent Development
 Table 98. SERION Immunologics Company Details
 Table 99. SERION Immunologics Business Overview
 Table 100. SERION Immunologics Rubella Recombinant Antigen Product
 Table 101. SERION Immunologics Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 102. SERION Immunologics Recent Development
 Table 103. ViroGen Corporation Company Details
 Table 104. ViroGen Corporation Business Overview
 Table 105. ViroGen Corporation Rubella Recombinant Antigen Product
 Table 106. ViroGen Corporation Revenue in Rubella Recombinant Antigen Business (2019-2024) & (US$ Million)
 Table 107. ViroGen Corporation Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Rubella Recombinant Antigen Picture
 Figure 2. Global Rubella Recombinant Antigen Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Rubella Recombinant Antigen Market Share by Type: 2023 VS 2030
 Figure 4. Rubella Protein Purity >90% Features
 Figure 5. Rubella Protein Purity >95% Features
 Figure 6. Rubella Protein Purity >98% Features
 Figure 7. Others Features
 Figure 8. Global Rubella Recombinant Antigen Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Rubella Recombinant Antigen Market Share by Application: 2023 VS 2030
 Figure 10. In Vitro Diagnostics Case Studies
 Figure 11. Vaccine Development Case Studies
 Figure 12. Others Case Studies
 Figure 13. Rubella Recombinant Antigen Report Years Considered
 Figure 14. Global Rubella Recombinant Antigen Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Rubella Recombinant Antigen Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Rubella Recombinant Antigen Market Share by Region: 2023 VS 2030
 Figure 17. Global Rubella Recombinant Antigen Market Share by Players in 2023
 Figure 18. Global Top Rubella Recombinant Antigen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Recombinant Antigen as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Rubella Recombinant Antigen Revenue in 2023
 Figure 20. North America Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Rubella Recombinant Antigen Market Share by Country (2019-2030)
 Figure 22. United States Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Rubella Recombinant Antigen Market Share by Country (2019-2030)
 Figure 26. Germany Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Rubella Recombinant Antigen Market Share by Region (2019-2030)
 Figure 34. China Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Rubella Recombinant Antigen Market Share by Country (2019-2030)
 Figure 42. Mexico Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Rubella Recombinant Antigen Market Share by Country (2019-2030)
 Figure 46. Turkey Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Rubella Recombinant Antigen Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Creative Biomart Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 50. RayBiotech Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 51. ProSpec Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 52. Abcam Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 54. Fapon Biotech Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 55. QED Bioscience Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 56. Cusabio Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 57. Meridian Bioscience Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 58. Native Antigen Company Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 59. SERION Immunologics Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 60. ViroGen Corporation Revenue Growth Rate in Rubella Recombinant Antigen Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Rubella Virus Antigen Market Research Report 2025
Global Toxoplasma Gondii Recombinant Antigen Market Research Report 2024
Global Recombinant Antibody Market Research Report 2025
Global H Pylori Recombinant Antigen Market Research Report 2024
Global Recombinant Influenza Vaccine Market Research Report 2024
Global Gene Recombinant Protein Market Research Report 2024
Global Rubella ELISA Kits Market Research Report 2024
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Recombinant Protein Industrial Reagents Market Research Report 2024
Rubella Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Measles and Rubella Vaccine Market Research Report 2025
Global Recombinant Vector Vaccines Market Insights Forecast to 2030
Recombinant Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Trypsin Market Insights Forecast to 2030
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Protein Peptide Drug Market Research Report 2024
Global Genetically Engineered Vector Vaccine Market Research Report 2024
Global Recombinant Human Thrombin Protein Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions